CLINICAL_TRIALS
trial_result
· 2020-06-12
Clinical Trial Update: A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes [Phase 3]
Summary
Phase 3 trial update on dulaglutide (LY2189265) for type 2 diabetes completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2020-06-12